Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Human Genome Sciences completes transaction establishing CoGenesys as independent company
July 14th, 2006
Human Genome Sciences, Inc., (HGSI) (HGS) announced that it has completed the transaction establishing its CoGenesys division as an independent company that will focus on the early development of selected gene-based product opportunities and the monetization of certain HGS intellectual property and technology assets. CoGenesys also announced the completion of a $55 million series A financing. "Through this transaction, HGS will realize value from certain intellectual property assets, and early stage product opportunities that we do not plan to develop internally," said H. Thomas Watkins, president and CEO, Human Genome Sciences. "HGS will benefit in...
Source: Genomics & Genetics Weekly (2006-07-14)
|
